The Evolent IPO filing is a reminder that investing is often not rational.
Bookending the week is another medication item as CMS released detailed data on drug use by Medicare beneficiaries.
The annual Medscape physician compensation report reveals low growth for many of the most common specialties, but family medicine saw a 10% rise.
A recent report examines funding for startup health companies, especially those involved in “digital” health.
A Viewpoint in JAMA summarizes a recent Institute of Medicine report designed to rationalize quality measurement for health systems.
Starting off the week with more medication reports is a summary of the IMS report on drug use in America.
Need all your fingers and toes to count the Medicare “quality” initiatives doctors have to comply with, and many are responding with a certain finger to those programs.
TransUnion Healthcare issued a report on how patients are coping with the ongoing financial pressures related to their health care.
A report from Avalere suggests that the penalty for failing to have health insurance is too low to incent people to enroll.
Research in the New England Journal of Medicine evaluates early results from Medicare’s Pioneer accountable care organization initiative.